Acrodermatitis Enteropathica - Dermatology Notes

Definition: A rare, autosomal recessive disorder of zinc deficiency caused by mutations in the SLC39A4 gene, which encodes the zinc transport protein ZIP4. Impaired intestinal zinc absorption leads to characteristic acral and periorificial dermatitis, alopecia, and diarrhea.

Key Clinical Features:

• Onset: Within weeks to months after birth if breastfed; earlier in formula-fed infants (zinc bioavailability lower in cow's milk). Also presents in adulthood as acquired zinc deficiency (nutritional, iatrogenic, or malabsorptive).

• Triad (classic but not always complete): Dermatitis, alopecia, diarrhea.

• Dermatitis distribution: Acral (hands, feet, digits) and periorificial (perioral, periocular, perinasal, perianal, genital) – symmetrically distributed.

• Morphology: Erythematous, well-demarcated plaques → evolve into vesicles, bullae, pustules, crusted erosions. Later becomes psoriasiform, scaly, and crusted.

• Characteristic sign: "Ring of crust" at the periphery of erosions.

• Alopecia: Diffuse or patchy; includes scalp hair, eyelashes, eyebrows.

• Diarrhea: Chronic, watery, often intermittent (present in 80%).

• Nails: Dystrophic, paronychia, Beau lines, onychodystrophy.

• Eyes: Blepharitis, conjunctivitis, photophobia (due to periorbital involvement).

• Behavioral changes: Irritability, apathy, anorexia.

• Growth retardation: Linear and weight.

• Immunodeficiency: Increased susceptibility to infections (Candida, bacterial) due to T-cell dysfunction.

Associated Conditions/Diseases:

• Acquired zinc deficiency (not true acrodermatitis enteropathica but mimics it):

  • Nutritional: Breastfed premature infants (low maternal zinc), total parenteral nutrition without zinc supplementation, alcoholism, anorexia nervosa.

  • Malabsorption: Crohn disease, cystic fibrosis, short bowel syndrome, pancreatic insufficiency.

  • Iatrogenic: Penicillamine (chelates zinc), sodium valproate, certain diuretics.

  • Inherited transient neonatal zinc deficiency: Caused by maternal SLC30A2 mutation (impaired zinc secretion into breast milk).

• Biotinidase deficiency: Clinically similar (acral/periorificial dermatitis, alopecia) but also has neurological features (seizures, hypotonia, hearing loss) and metabolic acidosis.

• Essential fatty acid deficiency: Similar rash but usually in parenteral nutrition without lipid supplementation.

• Necrolytic migratory erythema (glucagonoma syndrome): Similar distribution but has migratory, waxing/waning annular pattern, associated with glucagonoma, diabetes, weight loss, and thromboembolism.

Prognosis:

• Excellent with lifelong zinc supplementation – Complete resolution of symptoms within days to weeks.

• Untreated disease: Progressive malnutrition, severe infections, and death in early childhood.

• Acquired forms: Resolve with correction of underlying cause.

Differential Diagnosis:

• Dermatitis (atopic, contact, seborrheic): No acral/periorificial predominance, no alopecia, no diarrhea.

• Candidiasis (cutaneous or mucocutaneous): Satellitosis, oral thrush, no alopecia or diarrhea.

• Pemphigus foliaceus or vulgaris: Flaccid bullae, positive Nikolsky, immunofluorescence positive, no zinc deficiency.

• Biotinidase deficiency: Similar rash plus neurological findings (seizures, developmental delay), metabolic acidosis, elevated lactate.

• Necrolytic migratory erythema: Migratory annular pattern, associated with glucagonoma, weight loss, diabetes.

• Hailey–Hailey disease: Flexural involvement, positive family history, histology shows acantholysis.

• Psoriasis: Silvery scale, extensor surfaces, no alopecia or diarrhea.

Management with Rationale:

1. Zinc supplementation (life-long for genetic AE):

   • Elemental zinc: 1–3 mg/kg/day of elemental zinc (typically zinc sulfate, zinc acetate, or zinc gluconate). Start at 3 mg/kg/day.

   • Response: Clinical improvement within 24–48 hours; rash resolves in 1–2 weeks; alopecia regrows in 2–4 weeks.

   • Dose adjustment: Titrate to maintain normal serum zinc levels (70–120 mcg/dL) and clinical remission.

2. Dietary modification: Breast milk has higher zinc bioavailability than cow's milk (due to different binding proteins). For formula-fed infants, switch to zinc-fortified formula.

3. Treat secondary infections: Topical or systemic antifungals for candidiasis; antibiotics for bacterial superinfection.

4. Acquired zinc deficiency: Identify and correct underlying cause (supplement zinc, treat malabsorption, stop chelating drugs).

5. Monitoring: Serum zinc, alkaline phosphatase (zinc-dependent enzyme – low levels correlate with zinc deficiency), and clinical assessment.

Rationale for zinc: Zinc is a cofactor for over 300 enzymes (DNA polymerase, RNA polymerase, alkaline phosphatase, superoxide dismutase, metallothionein). Deficiency impairs cell division, immune function, and wound healing.

Histopathology

1. FOUNDATIONS (First Principles)

• Normal epidermis: Stratified squamous epithelium with orderly maturation. Zinc is essential for DNA synthesis, cell division, and keratinocyte differentiation.

• Zinc-dependent enzymes in skin:

  • DNA and RNA polymerases – required for keratinocyte proliferation.

  • Metallothionein – zinc storage and antioxidant defense.

  • Alkaline phosphatase – marker of zinc status (located in keratinocyte cell membranes).

  • Superoxide dismutase (SOD) – antioxidant protection.

• Normal zinc homeostasis: Zinc is absorbed in small intestine (duodenum and jejunum) via ZIP4 (SLC39A4). Serum zinc is bound to albumin and alpha-2-macroglobulin.

2. INITIATING EVENT

• Genetic (acrodermatitis enteropathica): Loss-of-function mutations in SLC39A4 on chromosome 8q24.3 → defective ZIP4 protein → impaired intestinal zinc uptake from the lumen into enterocytes → systemic zinc deficiency.

• Acquired zinc deficiency: Inadequate intake, malabsorption, or excessive loss (burns, diarrhea, chelation).

3. PATHOGENESIS

• Low serum zinc → reduced intracellular zinc in keratinocytes and rapidly dividing cells.

• Impaired DNA and RNA synthesis → decreased cell proliferation → epidermal thinning, reduced mitotic activity.

• Abnormal keratinocyte differentiation → parakeratosis, dyskeratosis, and loss of granular layer.

• Impaired desmosome formation → acantholysis and intraepidermal vesiculation (acantholytic dyskeratosis).

• Reduced antioxidant defense (decreased SOD and metallothionein) → increased susceptibility to oxidative damage and inflammation.

• Immune dysfunction (T-cell lymphopenia, impaired neutrophil chemotaxis) → susceptibility to Candida and bacterial infections (explains pustules and crusting).

• Why acral and periorificial distribution? Regions of highest epidermal turnover (friction, moisture, and trauma) have higher zinc requirements. Also, these areas have lower baseline zinc levels and are more susceptible to deficiency.

4. HISTOPATHOLOGY EXPLAINED (CRITICAL)

Low power:

• Psoriasiform hyperplasia (regular elongation of rete ridges – but unlike psoriasis, not uniform).

• Alternating parakeratosis and orthokeratosis (may mimic PRP but without follicular plugging).

• Confluent parakeratosis in some areas.

• Loss of granular layer (hypogranulosis) in parakeratotic regions.

• Intraepidermal vesiculation (pustules or clefts).

High power – diagnostic features:

• Acantholytic dyskeratosis – rounded, detached keratinocytes (acantholysis) with eosinophilic, pyknotic nuclei (dyskeratosis). This is the histologic hallmark.

• Pale, vacuolated keratinocytes (ballooning degeneration) in the mid and upper spinous layers.

• Necrotic keratinocytes (apoptotic cells) scattered throughout the epidermis.

• Spongiosis (intercellular edema) – mild to moderate.

• Neutrophilic pustules (intraepidermal or subcorneal) – often associated with candidal superinfection.

• Dilated superficial dermal capillaries.

• Perivascular lymphohistiocytic infiltrate (may have plasma cells and eosinophils).

Dermis:

• Papillary dermal edema.

• Superficial perivascular infiltrate (lymphocytes, histiocytes, occasional neutrophils).

• No vasculitis.

Why this appearance:

• Acantholytic dyskeratosis – Zinc deficiency impairs desmosome assembly and induces premature apoptosis (dyskeratosis) → keratinocytes round up and separate.

• Parakeratosis + hypogranulosis – Abnormal terminal differentiation due to impaired DNA synthesis in keratinocytes.

• Ballooning degeneration – Intracellular edema from impaired membrane integrity (zinc is essential for membrane stabilization).

• Pustules – Superimposed candidiasis (Candida albicans) is common because zinc deficiency impairs cell-mediated immunity.

Board critical point: The combination of acantholytic dyskeratosis and psoriasiform hyperplasia in a periorificial or acral distribution is highly suggestive of acrodermatitis enteropathica or its mimics (biotinidase deficiency, necrolytic migratory erythema).

5. NAMING LOGIC & TERMINOLOGY

• Acrodermatitis – Inflammation of the skin on the extremities (acro = extremity, dermatitis = skin inflammation).

• Enteropathica – Related to intestinal disease (entero = intestine, pathica = suffering).

• Acantholytic dyskeratosis – Loss of adhesion (acantholysis) combined with abnormal, premature keratinization (dyskeratosis). This pattern is also seen in Darier disease, Grover disease, and warty dyskeratoma.

• Psoriasiform hyperplasia – Regular elongation of rete ridges resembling psoriasis (but without the other features of psoriasis).

6. STAINING & MARKERS

H&E: Diagnostic as described above. Acantholytic dyskeratosis is the key.

Special stains:

• PAS with diastase: May highlight fungal hyphae (Candida) in the stratum corneum – secondary infection is common.

• GMS (Gomori methenamine silver): More sensitive for fungal elements.

• Tissue zinc staining (rubeanic acid or dithizone): Not clinically useful; requires fresh frozen tissue and is not routinely performed.

Immunohistochemistry (not diagnostic, research):

• ZIP4 (SLC39A4): Reduced or absent expression in duodenal biopsies (not skin) in genetic AE. Not used for skin biopsy diagnosis.

• Ki-67: Reduced proliferative index in basal layer (contradicts psoriasiform hyperplasia? In AE, psoriasiform hyperplasia is a reactive change, but individual keratinocyte proliferation is impaired – complex).

• p53: May show scattered positive cells (apoptotic keratinocytes).

Serologic studies (for diagnosis, not histology):

• Serum zinc: Low (<50 mcg/dL; normal 70–120 mcg/dL). Confirm with repeat morning sample (diurnal variation).

• Serum alkaline phosphatase: Low (zinc-dependent enzyme; correlates with zinc status).

• Serum copper: May be elevated (zinc deficiency reduces metallothionein, leading to unopposed copper absorption).

• Urinary zinc excretion: Variable.

Genetic testing: SLC39A4 mutation analysis for confirmation in genetic AE.

7. TEMPORAL EVOLUTION

• Early lesion (erythematous macule): Mild spongiosis, scattered dyskeratotic keratinocytes, minimal acantholysis.

• Established lesion (vesiculopustular plaque): Florid acantholytic dyskeratosis, psoriasiform hyperplasia, parakeratosis, hypogranulosis, intraepidermal pustules (often with Candida).

• Chronic lesion (scaly, crusted plaque): Marked psoriasiform hyperplasia, hyperkeratosis, less acantholysis, secondary changes (lichenification, excoriation).

• Treated lesion (after zinc supplementation, days to weeks): Rapid normalization – acantholysis resolves, granular layer reappears, parakeratosis becomes orthokeratosis, inflammatory infiltrate clears. Complete histologic resolution in 1–2 weeks.

8. PATTERN RECOGNITION & DIAGNOSTIC LOGIC

• Pattern: Acantholytic dyskeratosis + psoriasiform hyperplasia + parakeratosis + hypogranulosis + periorificial/acral distribution (clinical correlation essential).

Diagnostic pathway:

• Acantholytic dyskeratosis + psoriasiform hyperplasia + low serum zinc + periorificial/acral rash in infant → Acrodermatitis enteropathica (genetic).

• Acantholytic dyskeratosis + psoriasiform hyperplasia + low serum zinc + history of malabsorption or nutritional deficiency → Acquired zinc deficiency.

• Acantholytic dyskeratosis + psoriasiform hyperplasia + normal serum zinc + neurological symptoms (seizures, hypotonia) + metabolic acidosis → Biotinidase deficiency (check serum biotinidase activity).

• Acantholytic dyskeratosis + psoriasiform hyperplasia + migratory annular rash + diabetes + weight loss + elevated glucagon → Necrolytic migratory erythema (glucagonoma).

• Acantholytic dyskeratosis without psoriasiform hyperplasia + greasy, crusted papules in seborrheic areas + positive family history (autosomal dominant) → Darier disease (different distribution, normal zinc).

• Acantholytic dyskeratosis + suprabasal clefting + immunofluorescence negative + intermittent flares → Hailey–Hailey disease (flexural, normal zinc).

Key discriminator from Darier disease:

• Acrodermatitis enteropathica: Acantholytic dyskeratosis + psoriasiform hyperplasia + parakeratosis + periorificial/acral distribution + low serum zinc.

• Darier disease: Acantholytic dyskeratosis + corps ronds and grains (specific forms of dyskeratosis) + suprabasal clefting + seborrheic distribution (central trunk, scalp, flexures) + no zinc deficiency.

9. CLINICO-PATHOLOGICAL CORRELATION

• Periorificial and acral rash → High epidermal turnover regions have greatest zinc demand; also exposure to moisture and friction.

• Vesicles, bullae, pustules → Acantholytic dyskeratosis creates intraepidermal clefts that fill with fluid; superimposed Candida causes pustules.

• Crusted, psoriasiform plaques → Psoriasiform hyperplasia and parakeratosis.

• Alopecia → Zinc deficiency impairs rapidly dividing hair matrix keratinocytes → dystrophic anagen effluvium.

• Diarrhea → Intestinal epithelial cells also rapidly dividing; zinc deficiency causes villous atrophy and malabsorption (paradoxically exacerbating deficiency).

• Failure to thrive, immune deficiency → Impaired DNA synthesis in all rapidly dividing cells (immune cells, enterocytes, fibroblasts).

• Rapid improvement with zinc → Corrects intracellular zinc levels within hours; DNA synthesis resumes; desmosome assembly normalizes.

10. EXAM-FOCUSED INSIGHTS

• Periorificial + acral dermatitis + alopecia + diarrhea in an infant = acrodermatitis enteropathica until proven otherwise – Board classic.

• Acantholytic dyskeratosis on histology is the hallmark – But this pattern is not specific (also Darier, Grover, necrolytic migratory erythema, biotinidase deficiency). Clinical correlation is essential.

• Low serum zinc confirms the diagnosis – But note: serum zinc is falsely low in hypoalbuminemia (80% of zinc is albumin-bound). Also, acute illness and inflammation lower serum zinc (acute phase reactant).

• Alkaline phosphatase is a useful surrogate marker – Zinc is a cofactor; low ALP supports zinc deficiency.

• Response to zinc challenge is diagnostic – Clinical improvement within 24–48 hours is pathognomonic.

• Biotinidase deficiency is the great mimicker – Same rash, same histology, same alopecia. Differentiate with neurological findings (seizures, hypotonia, developmental delay), metabolic acidosis, and elevated lactate. Check serum biotinidase.

• Necrolytic migratory erythema (glucagonoma syndrome) is the adult board mimic – Same histology (acantholytic dyskeratosis), but rash is migratory, annular, and waxing/waning. Associated with diabetes, weight loss, and thromboembolism. Serum glucagon is elevated.

• Acquired zinc deficiency is more common than genetic AE – Think of premature infants, TPN without zinc, alcoholics, Crohn disease, and penicillamine use.

• Do NOT confuse with candidiasis alone – Candidiasis does not cause alopecia, diarrhea, or acantholytic dyskeratosis on histology.

• Zinc supplementation is life-long for genetic AE – Dose must be maintained; growth and pregnancy increase requirements.

• Maternal transient neonatal zinc deficiency – Infant has AE phenotype, mother is asymptomatic but has SLC30A2 mutation (impaired zinc secretion into breast milk). Infant improves with zinc-fortified formula.

Must-Know Board Exam Questions & Answers

Q1: A 4-month-old exclusively breastfed infant presents with an erythematous, crusted, psoriasiform rash around the mouth, eyes, and anus, along with the hands and feet. The infant also has alopecia and watery diarrhea. What is the most likely diagnosis?

A: Acrodermatitis enteropathica.

Q2: What is the histopathological hallmark of acrodermatitis enteropathica?

A: Acantholytic dyskeratosis – rounded, detached keratinocytes (acantholysis) with eosinophilic, pyknotic nuclei (dyskeratosis).

Q3: What gene is mutated in inherited acrodermatitis enteropathica, and what protein does it encode?

A: SLC39A4, encoding the zinc transport protein ZIP4, which mediates intestinal zinc absorption.

Q4: A skin biopsy from a patient with periorificial dermatitis shows acantholytic dyskeratosis and psoriasiform hyperplasia. Serum zinc is normal. The patient has a history of seizures and developmental delay. What is the most likely diagnosis?

A: Biotinidase deficiency. (Same histology as AE but with neurological features and normal zinc.)

Q5: What is the expected response time to zinc supplementation in acrodermatitis enteropathica?

A: Clinical improvement within 24–48 hours; rash resolves in 1–2 weeks; alopecia regrows in 2–4 weeks.

Q6: A 55-year-old with diabetes and weight loss presents with a migratory, annular, erythematous rash in the periorificial and acral distribution. Biopsy shows acantholytic dyskeratosis. What is the most likely diagnosis?

A: Necrolytic migratory erythema (glucagonoma syndrome). Check serum glucagon and image the pancreas.

Q7: Name two serum laboratory abnormalities that support zinc deficiency (other than low serum zinc).

A: Low serum alkaline phosphatase (zinc-dependent enzyme) and elevated serum copper (reduced metallothionein leads to unopposed copper absorption).

Q8: A breastfed infant develops acrodermatitis enteropathica-like rash, but the mother is asymptomatic. The infant improves dramatically with zinc-fortified formula. What is the underlying defect?

A: Maternal transient neonatal zinc deficiency – caused by maternal SLC30A2 mutation, which impairs zinc secretion into breast milk. The infant is normal.

Q9: What are the three components of the classic triad of acrodermatitis enteropathica?

A: Dermatitis (acral and periorificial), alopecia, and diarrhea.

Q10: Why is breast milk recommended over cow's milk for infants with acrodermatitis enteropathica?

A: Breast milk has higher zinc bioavailability due to different zinc-binding proteins compared to cow's milk.